Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Munoz

Showing results (261-270 of 276) with videos related to

Pageof 28
Sort By:
The Journal of Pathology|February 14, 2018
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's diseaseAndre F Batista, Leticia Forny-Germano, Julia R Clarke, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI)Manuel Montero-Odasso, Frederico Pieruccini-Faria, Robert Bartha, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 23, 2016
The Ontario Neurodegenerative Disease Research Initiative (ONDRI)Sali M K Farhan, Robert Bartha, Sandra E Black, et al.
Cell Metabolism|December 10, 2013
TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeysMychael V Lourenco, Julia R Clarke, Rudimar L Frozza, et al.
Journal of Neurology|October 27, 2021
Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative diseaseF Elizabeth Godkin, Erin Turner, Youness Demnati, et al.
EMBO Molecular Medicine|January 25, 2015
Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulationJulia R Clarke, Natalia M Lyra E Silva, Claudia P Figueiredo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2014
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and othersA M Tortorano, M Richardson, E Roilides, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotypeMichitaka Nakano, Lyong Heo, Yu-Ping Yang, et al.
International Journal of Geriatric Psychiatry|May 28, 2022
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeDerek Beaton, Paula M McLaughlin, Joseph B Orange, et al.
Pageof 28

Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
The Journal of Pathology|February 14, 2018
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's diseaseAndre F Batista, Leticia Forny-Germano, Julia R Clarke, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI)Manuel Montero-Odasso, Frederico Pieruccini-Faria, Robert Bartha, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 23, 2016
The Ontario Neurodegenerative Disease Research Initiative (ONDRI)Sali M K Farhan, Robert Bartha, Sandra E Black, et al.
Cell Metabolism|December 10, 2013
TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeysMychael V Lourenco, Julia R Clarke, Rudimar L Frozza, et al.
Journal of Neurology|October 27, 2021
Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative diseaseF Elizabeth Godkin, Erin Turner, Youness Demnati, et al.
EMBO Molecular Medicine|January 25, 2015
Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulationJulia R Clarke, Natalia M Lyra E Silva, Claudia P Figueiredo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2014
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and othersA M Tortorano, M Richardson, E Roilides, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotypeMichitaka Nakano, Lyong Heo, Yu-Ping Yang, et al.
International Journal of Geriatric Psychiatry|May 28, 2022
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeDerek Beaton, Paula M McLaughlin, Joseph B Orange, et al.
Pageof 28